Third time in RESPECT Index for Pelion
Pelion S.A. has secured a place in the 8th edition of the RESPECT Index, again confirming its compliance with the highest standards of responsible and sustainable business conduct.
It is the third time that Pelion S.A. has featured in the RESPECT Index, which highlights companies managed in a sustainable and responsible manner.
The official announcement of the Index review results and presentation of membership certificates took place at the offices of the Warsaw Stock Exchange on December 18th 2014.
A total of 24 companies qualified for inclusion in the 8th edition of the Index. During the multi-stage qualification process, the extent and the level of complexity of stakeholder engagement activities were thoroughly analysed. Among the evaluated areas were business management strategies and techniques, HR and environmental policies, as well as market- and customer-oriented initiatives.
The certificate confirming Pelion S.A.’s RESPECT Index membership was received by Lidia Kołucka-Żuk, Director of Communication Strategy, from Paweł Tamborski, President of the WSE Management Board.
“Our inclusion in the RESPECT Index for the third time proves that the Pelion Healthcare Group runs its business in a responsible and sustainable manner. To be part of the list again is not only a great honour, but – first and foremost – it is a responsibility towards our stakeholders,” stressed Mariola Belina-Prażmowska, Vice-President of the Pelion Management Board for Development and Investor Relations.
New qualifying rules have been introduced with the 7th edition of the RESPECT Index. Companies are now analysed from the relevant industry’s perspective, with the main areas of focus being their environmental, social and management performance. In its new form, the Index is also open to foreign companies. The rankings are updated annually.
Those included in the 8th RESPECT Index will keep their title until December 22nd 2014.
RESPECT Index is the first index of socially responsible companies (SRI) in Central and Eastern Europe. It includes companies with highest liquidity, which are market leaders in corporate governance, quality reporting and investor relations, and which stand out for their pro-environmental, social and employee-oriented activities. The RESPECT Index constituents are chosen from among the largest companies listed in the WIG20, mWIG40 and sWIG80 indices. The Index represents a valid point of reference for stock market investors, who want to be sure that they invest in highly-liquid companies run to the best-in-class standards of management. In the period from November 19th 2009, when the first RESPECT Index was announced, until December 2014, the Index generated a 70% rate of return.
The official announcement of the Index review results and presentation of membership certificates took place at the offices of the Warsaw Stock Exchange on December 18th 2014.
A total of 24 companies qualified for inclusion in the 8th edition of the Index. During the multi-stage qualification process, the extent and the level of complexity of stakeholder engagement activities were thoroughly analysed. Among the evaluated areas were business management strategies and techniques, HR and environmental policies, as well as market- and customer-oriented initiatives.
The certificate confirming Pelion S.A.’s RESPECT Index membership was received by Lidia Kołucka-Żuk, Director of Communication Strategy, from Paweł Tamborski, President of the WSE Management Board.
“Our inclusion in the RESPECT Index for the third time proves that the Pelion Healthcare Group runs its business in a responsible and sustainable manner. To be part of the list again is not only a great honour, but – first and foremost – it is a responsibility towards our stakeholders,” stressed Mariola Belina-Prażmowska, Vice-President of the Pelion Management Board for Development and Investor Relations.
New qualifying rules have been introduced with the 7th edition of the RESPECT Index. Companies are now analysed from the relevant industry’s perspective, with the main areas of focus being their environmental, social and management performance. In its new form, the Index is also open to foreign companies. The rankings are updated annually.
Those included in the 8th RESPECT Index will keep their title until December 22nd 2014.
RESPECT Index is the first index of socially responsible companies (SRI) in Central and Eastern Europe. It includes companies with highest liquidity, which are market leaders in corporate governance, quality reporting and investor relations, and which stand out for their pro-environmental, social and employee-oriented activities. The RESPECT Index constituents are chosen from among the largest companies listed in the WIG20, mWIG40 and sWIG80 indices. The Index represents a valid point of reference for stock market investors, who want to be sure that they invest in highly-liquid companies run to the best-in-class standards of management. In the period from November 19th 2009, when the first RESPECT Index was announced, until December 2014, the Index generated a 70% rate of return.
For further information, please contact:
Pelion S.A. Press Office
Phone: (+48 42) 200 75 94
Fax: (+48 42) 200 75 35
Email: biuro_prasowe@pelion.eu
Pelion S.A. has operated on the market for twenty-four years, starting out as a local pharmaceutical wholesaler. In 1998, the Company shares were floated on the Warsaw Stock Exchange. Proceeds from the initial public offering fuelled the Company’s dynamic growth and allowed it to embark on consolidation of the pharmaceutical wholesale market. Since its flotation, the Company has secured a top position among domestic distributors of medicinal products. Today, Pelion Healthcare Group is one of the largest groups operating in the healthcare markets in Poland and Lithuania. It provides services across all market segments (wholesale, retail sales and sales to hospitals), targeted at individual patients, pharmacies, hospitals, and manufacturers. As a holding company, Pelion S.A. oversees all areas of the Company’s operations, which are conducted by PGF S.A. and Pharmapoint Sp. z o.o. (wholesale), PGF Urtica Sp. z o.o. (hospital sales), CEPD N.V. (retail sales), and Pharmalink Sp. z o.o. (services for manufacturers).
